$20.84
4.30% today
Nasdaq, May 02, 05:48 pm CET
ISIN
US8753722037
Symbol
TNDM

Tandem Diabetes Care, Inc. Stock price

$19.98
+1.25 6.67% 1M
-11.93 37.39% 6M
-16.04 44.53% YTD
-16.22 44.81% 1Y
-77.78 79.56% 3Y
-60.24 75.09% 5Y
-117.12 85.43% 10Y
Nasdaq, Closing price Thu, May 01 2025
+3.13 18.58%
ISIN
US8753722037
Symbol
TNDM
Sector

Key metrics

Market capitalization $1.33b
Enterprise Value $1.37b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 273.58
EV/Sales (TTM) EV/Sales 1.45
P/S ratio (TTM) P/S ratio 1.41
P/B ratio (TTM) P/B ratio 5.03
Revenue growth (TTM) Revenue growth 25.74%
Revenue (TTM) Revenue $940.20m
EBIT (operating result TTM) EBIT $-99.13m
Free Cash Flow (TTM) Free Cash Flow $4.99m
Cash position $438.33m
EPS (TTM) EPS $-1.47
P/E forward negative
P/S forward 1.33
EV/Sales forward 1.36
Short interest 13.36%
Show more

Is Tandem Diabetes Care, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,792 stocks worldwide.

Tandem Diabetes Care, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

25 Analysts have issued a Tandem Diabetes Care, Inc. forecast:

14x Buy
56%
10x Hold
40%
1x Sell
4%

Analyst Opinions

25 Analysts have issued a Tandem Diabetes Care, Inc. forecast:

Buy
56%
Hold
40%
Sell
4%

Financial data from Tandem Diabetes Care, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
940 940
26% 26%
100%
- Direct Costs 451 451
19% 19%
48%
490 490
33% 33%
52%
- Selling and Administrative Expenses 373 373
11% 11%
40%
- Research and Development Expense 199 199
17% 17%
21%
-83 -83
41% 41%
-9%
- Depreciation and Amortization 17 17
6% 6%
2%
EBIT (Operating Income) EBIT -99 -99
36% 36%
-11%
Net Profit -96 -96
57% 57%
-10%

In millions USD.

Don't miss a Thing! We will send you all news about Tandem Diabetes Care, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tandem Diabetes Care, Inc. Stock News

Neutral
Seeking Alpha
one day ago
Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Susan Morrison - EVP & Chief Administrative Officer John Sheridan - President & CEO Leigh Vosseller - EVP & CFO Conference Call Participants Matt Miksic - Barclays Mat Blackman - Stifel Steve Lichtman - Oppenheimer & Company Matthew O'Brien - Piper Sandler David Roman - Gold...
Neutral
Business Wire
2 days ago
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2025. First Quarter 2025 Highlights, Financial Results Compared to First Quarter 2024 Achieved record first quarter sales with worldwide growth of 22% Increased pump sales in the United States by 19...
Negative
The Motley Fool
20 days ago
With equity markets reeling due to President Donald Trump's tariffs, many investors are taking this opportunity to buy shares of top companies on the dip. It's a great strategy, but it's essential to avoid those companies that only look undervalued but actually aren't.
More Tandem Diabetes Care, Inc. News

Company Profile

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Head office United States
CEO John Sheridan
Employees 2,650
Founded 2006
Website www.tandemdiabetes.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today